NCT04117750View on ClinicalTrials.gov

Impact of Vitamin D Supplementation on Cardiometabolic Status and Androgen Profile in Polycystic Ovary Syndrome

NACompletedINTERVENTIONAL
Enrollment

145

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

April 1, 2018

Study Completion Date

July 1, 2018

Conditions
Evaluations, Diagnostic SelfTreatment Adherence
Interventions
DIETARY_SUPPLEMENT

cholecalciferol (vit D3)

42,000 IU oral vitamin D per week and 500 mg calcium carbonate

Trial Locations (1)

44519

Zagazig University, Zagazig

All Listed Sponsors
lead

Zagazig University

OTHER_GOV

NCT04117750 - Impact of Vitamin D Supplementation on Cardiometabolic Status and Androgen Profile in Polycystic Ovary Syndrome | Biotech Hunter | Biotech Hunter